AVDL vs PSX · rev $169.1M vs P/E 17, rev $83.54B
Avadel Pharmaceuticals PLC (AVDL) versus Phillips 66 (PSX) — a side-by-side from cached financials, not a winner call.
Avadel Pharmaceuticals PLC (AVDL) is a drug manufacturers - specialty & generic company listed on US.
Phillips 66 (PSX) is a oil & gas refining & marketing company listed on NYSE.
Latest reported AVDL revenue for 2024-12-31 was $169.1M. Net income was -$48.8M. Revenue was up 504.8% from 2023-12-31 to 2024-12-31. AVDL currently screens at market cap $968.5M.
Latest reported PSX revenue for 2026-06-30 was $83.54B. Net income was $4.05B. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
AVDL currently screens at market cap $968.5M. PSX currently screens at market cap $67.02B and trailing P/E 16.5.
Not investment advice. Open the AVDL and PSX stock pages for the full models.
Not investment advice.